0000929638-25-002511.txt : 20250703 0000929638-25-002511.hdr.sgml : 20250703 20250703134627 ACCESSION NUMBER: 0000929638-25-002511 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250703 DATE AS OF CHANGE: 20250703 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Clearmind Medicine Inc. CENTRAL INDEX KEY: 0001892500 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-93839 FILM NUMBER: 251104911 BUSINESS ADDRESS: STREET 1: 101-1220 WEST 6TH AVENUE CITY: VANCOUVER, BRITISH COLUMBIA STATE: Z4 ZIP: V6H1A5 BUSINESS PHONE: 972-54-5704749 MAIL ADDRESS: STREET 1: 101-1220 WEST 6TH AVENUE CITY: VANCOUVER, BRITISH COLUMBIA STATE: Z4 ZIP: V6H1A5 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AdvisorShares Trust CENTRAL INDEX KEY: 0001408970 ORGANIZATION NAME: EIN: 260636087 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: 4800 MONTGOMERY LANE STREET 2: SUITE 150 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (877) 843-3831 MAIL ADDRESS: STREET 1: 4800 MONTGOMERY LANE STREET 2: SUITE 150 CITY: BETHESDA STATE: MD ZIP: 20814 SCHEDULE 13G/A 1 primary_doc.xml SCHEDULE 13G/A 0000929638-24-000612 0001408970 XXXXXXXX LIVE 1 Common Shares, no par value 06/30/2025 0001892500 Clearmind Medicine Inc. 185053402 101 - 1220 W 6 Avenue, Vancouver BC Z4 V6H1A5 Rule 13d-1(b) AdvisorShares Trust DE 205933 0 205933 0 205933 N 4.83 IV Clearmind Medicine Inc. 101 - 1220 W 6 Avenue, Vancouver, BC, Canada (Federal Level), V6H1A5 AdvisorShares Trust 4800 Montgomery Lane, Suite 150 Bethesda, Maryland 20814 Delaware N IV 205,933 4.83% 205,933 0 205,933 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. AdvisorShares Trust /s/ Stefanie Little 07/03/2025